SUPPRELIN LA (histrelin SC implant)

OFFICE ADMINISTRATION 

Indications for Prior Authorization:

  • Central precocious puberty

Patients must meet the following criteria for the indication(s) above:

  • Patients two years and older. Discontinue at age 11 years for girls and 12 years for boys

All of the following must be met as a condition(s) for coverage:

  • Age between two and 12 years
  • Trial/failure/adverse effects of leuprolide depot
    • 0.3mg/kg/dose IM q month (Lupron Depot PED [one month]) OR
    • 11.25mg to 30mg IM q 3 months (Lupron Depot PED [3 month])

The Following Conditions Do Not Meet the Criteria for Use as Established by the WHA P & T Committee:

  • Idiopathic short stature
  • Ovarian cancer
  • Prophylaxis for chemo therapy induced gonadal injury
  • Considered experimental and investigational for all other indications outside of the FDA indication because there is insufficient evidence in peer reviewed literature

Dose:

  • One implant (50mg) q 12 months

Approval:

One year


 

Last review date: December 9, 2016

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone